Arcturus Therapeutics Holdings Inc (NAS:ARCT)
$ 7.35 +0.070 (+0.96%) Market Cap: 208.91 Mil Enterprise Value: 21.52 Mil PE Ratio: 0 PB Ratio: 1.09 GF Score: 56/100

Q1 2026 Arcturus Therapeutics Holdings Inc Earnings Call Transcript

May 07, 2026 / 08:30PM GMT
Release Date Price: $8.9 (-2.52%)
Operator

Hello and welcome everyone joining today's Arcturus Therapeutics' first-quarter 2026 earnings call. (Operator Instructions) Please note, this call is being recorded. We are standing by if you should need any assistance.

It is now my pleasure to turn the meeting over to Neda Safarzadeh, Vice President, Head of Investor Relations, Public Relations and Marketing. Please go ahead.

Neda Safarzadeh
Arcturus Therapeutics Inc - Vice President, Investor Relations, Public Relations and Marketing

Thank you, operator. Good afternoon, and welcome to Arcturus Therapeutics' quarterly financial update and pipeline progress call.

Today's call will be led by Joe Payne, our President and CEO; Dr. Alan Cohen, our Chief Medical Officer; and Dennis Mulroy, our Chief Financial Officer. Dr. Pat Chivukula, our CFO and COO, will join them for the Q&A session.

Before we begin, I would like to remind everyone that the statements made during call regarding matters that are not historical facts are forward-looking statements within the Safe Harbor

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot